These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Cloning of the gene for spinocerebellar ataxia 2 reveals a locus with high sensitivity to expanded CAG/glutamine repeats. Imbert G; Saudou F; Yvert G; Devys D; Trottier Y; Garnier JM; Weber C; Mandel JL; Cancel G; Abbas N; Dürr A; Didierjean O; Stevanin G; Agid Y; Brice A Nat Genet; 1996 Nov; 14(3):285-91. PubMed ID: 8896557 [TBL] [Abstract][Full Text] [Related]
23. New anti-huntingtin monoclonal antibodies: implications for huntingtin conformation and its binding proteins. Ko J; Ou S; Patterson PH Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):319-29. PubMed ID: 11719267 [TBL] [Abstract][Full Text] [Related]
24. Role of inositol 1,4,5-trisphosphate receptors in pathogenesis of Huntington's disease and spinocerebellar ataxias. Bezprozvanny I Neurochem Res; 2011 Jul; 36(7):1186-97. PubMed ID: 21210219 [TBL] [Abstract][Full Text] [Related]
25. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Trottier Y; Devys D; Imbert G; Saudou F; An I; Lutz Y; Weber C; Agid Y; Hirsch EC; Mandel JL Nat Genet; 1995 May; 10(1):104-10. PubMed ID: 7647777 [TBL] [Abstract][Full Text] [Related]
26. CAG repeat expansion in the TATA box-binding protein gene causes autosomal dominant cerebellar ataxia. Fujigasaki H; Martin JJ; De Deyn PP; Camuzat A; Deffond D; Stevanin G; Dermaut B; Van Broeckhoven C; Dürr A; Brice A Brain; 2001 Oct; 124(Pt 10):1939-47. PubMed ID: 11571212 [TBL] [Abstract][Full Text] [Related]
27. Reduced Levels of Proteasome Products in a Mouse Striatal Cell Model of Huntington's Disease. Dasgupta S; Fishman MA; Mahallati H; Castro LM; Tashima AK; Ferro ES; Fricker LD PLoS One; 2015; 10(12):e0145333. PubMed ID: 26691307 [TBL] [Abstract][Full Text] [Related]
28. Huntington's disease: new paths to pathogenesis. Ross CA Cell; 2004 Jul; 118(1):4-7. PubMed ID: 15242639 [TBL] [Abstract][Full Text] [Related]
29. Protein aggregation and pathogenesis of Huntington's disease: mechanisms and correlations. Wanker EE Biol Chem; 2000; 381(9-10):937-42. PubMed ID: 11076024 [TBL] [Abstract][Full Text] [Related]
30. Mapping of the epitope of monoclonal antibody 2B4 to the proline-rich region of human Huntingtin, a region critical for aggregation and toxicity. Dehay B; Weber C; Trottier Y; Bertolotti A Biotechnol J; 2007 May; 2(5):559-64. PubMed ID: 17373643 [TBL] [Abstract][Full Text] [Related]
31. Gain of glutamines, gain of function? Housman D Nat Genet; 1995 May; 10(1):3-4. PubMed ID: 7647786 [No Abstract] [Full Text] [Related]
32. Analysis of polyglutamine-coding repeats in the TATA-binding protein in different neurodegenerative diseases. Wu YR; Fung HC; Lee-Chen GJ; Gwinn-Hardy K; Ro LS; Chen ST; Hsieh-Li HM; Lin HY; Lin CY; Li SN; Chen CM J Neural Transm (Vienna); 2005 Apr; 112(4):539-46. PubMed ID: 15365789 [TBL] [Abstract][Full Text] [Related]
33. Peptide models for inherited neurodegenerative disorders: conformation and aggregation properties of long polyglutamine peptides with and without interruptions. Sharma D; Sharma S; Pasha S; Brahmachari SK FEBS Lett; 1999 Jul; 456(1):181-5. PubMed ID: 10452554 [TBL] [Abstract][Full Text] [Related]
34. Focal distortion of the nuclear envelope by huntingtin aggregates revealed by lamin immunostaining. Chapple JP; Bros-Facer V; Butler R; Gallo JM Neurosci Lett; 2008 Dec; 447(2-3):172-4. PubMed ID: 18840504 [TBL] [Abstract][Full Text] [Related]
35. FTLD-ALS of TDP-43 type and SCA2 in a family with a full ataxin-2 polyglutamine expansion. Bäumer D; East SZ; Tseu B; Zeman A; Hilton D; Talbot K; Ansorge O Acta Neuropathol; 2014 Oct; 128(4):597-604. PubMed ID: 24718895 [TBL] [Abstract][Full Text] [Related]